Concepedia

Mirjam Hermisson

MH

16

Publications

1.4K

Citations

16

H-Index

1998

Active since

Affiliations

University of Tübingen(Current)

Hertie Institute for Clinical Brain Research

University Children's Hospital Tübingen

Technical University of Munich

Translational Research in Oncology

Mirjam Hermisson is an author at University of Tübingen specializing in medicine, neuro-oncology, and pharmacology.

Top concepts

Publications per year

1998–2020

16

Publications

16

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma

Roger Stupp, Monika E. Hegi, Bart Neyns et al. · Journal of Clinical Oncology · 2010 · 439 citations · Full text

O<sup>6</sup>‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

Mirjam Hermisson, Andrea Klumpp, Wolfgang Wick et al. · Journal of Neurochemistry · 2006 · 311 citations · Full text

Proteasome Inhibitor‐Induced Apoptosis of Glioma Cells Involves the Processing of Multiple Caspases and Cytochrome <i>c</i> Release

Bettina Wagenknecht, Mirjam Hermisson, Peter Groscurth et al. · Journal of Neurochemistry · 2000 · 92 citations

Expression and functional activity of heat shock proteins in human glioblastoma multiforme

Mirjam Hermisson, Herwig Strik, Johannes Rieger et al. · Neurology · 2000 · 84 citations

Pharmacotherapy of Epileptic Seizures in Glioma Patients: Who, When, Why and How Long?

Wolfgang Wick, Oliver Menn, Christoph Meisner et al. · Oncology Research and Treatment · 2005 · 78 citations

Rows per page

1–5 of 16